D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.68B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$875M |
| 4 |
Tesla
TSLA
|
+$835M |
| 5 |
Eli Lilly
LLY
|
+$643M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$939M |
| 2 |
Palantir
PLTR
|
+$668M |
| 3 |
Apple
AAPL
|
+$644M |
| 4 |
Workday
WDAY
|
+$525M |
| 5 |
Spotify
SPOT
|
+$451M |
Sector Composition
| 1 | Technology | 20.55% |
| 2 | Consumer Discretionary | 13.27% |
| 3 | Healthcare | 12.29% |
| 4 | Financials | 8.39% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Designer Brands
DBI
$208M
| $8.46M | 0.01% |
1,583,727
+89,846
| +6% | +$480K |
|
952
Element Solutions
ESI
$6.34B
| $8.42M | 0.01% |
330,987
+311,649
| +1,612% | +$7.93M |
|
953
Freedom Holding
FRHC
$9.91B
| $8.41M | 0.01% |
64,369
+59,124
| +1,127% | +$7.73M |
|
954
Daktronics
DAKT
$1.13B
| $8.38M | 0.01% |
497,289
-38,652
| -7% | -$652K |
|
955
Alkami Technology
ALKT
$2.63B
| $8.35M | 0.01% |
+227,704
| New | +$8.35M |
|
956
Treace Medical Concepts
TMCI
$467M
| $8.3M | 0.01% |
1,115,826
-28,140
| -2% | -$209K |
|
957
Aclaris Therapeutics
ACRS
$219M
| $8.17M | 0.01% |
3,293,625
-78,224
| -2% | -$194K |
|
958
Fastenal
FAST
$54.1B
| $8.17M | 0.01% |
227,164
-68,448
| -23% | -$2.46M |
|
959
Liberty Global Class C
LBTYK
$4.11B
| $8.14M | 0.01% |
619,788
+181,631
| +41% | +$2.39M |
|
|
GIG
960
GigCapital7 Corp. Class A Ordinary Share
GIG
| $8.14M | 0.01% |
815,000
+318,717
| +64% | +$3.18M |
|
961
Pegasystems
PEGA
$9.86B
| $8.12M | 0.01% |
174,182
-320,322
| -65% | -$14.9M |
|
962
Essent Group
ESNT
$6.32B
| $8.12M | 0.01% |
149,078
+140,699
| +1,679% | +$7.66M |
|
963
Blue Bird Corp
BLBD
$1.84B
| $8.11M | 0.01% |
210,040
+17,530
| +9% | +$677K |
|
964
Expensify
EXFY
$180M
| $8.11M | 0.01% |
2,419,558
-305,540
| -11% | -$1.02M |
|
965
Bio-Rad Laboratories Class A
BIO
$7.63B
| $8.09M | 0.01% |
24,625
+7,837
| +47% | +$2.57M |
|
966
ASE Group
ASX
$24B
| $8.07M | 0.01% |
800,934
+177,418
| +28% | +$1.79M |
|
967
Axogen
AXGN
$763M
| $8.05M | 0.01% |
488,306
-146,038
| -23% | -$2.41M |
|
968
Advance Auto Parts
AAP
$3.67B
| $8.01M | 0.01% |
169,482
-3,718
| -2% | -$176K |
|
969
Elanco Animal Health
ELAN
$9.18B
| $8M | 0.01% |
660,639
-367,985
| -36% | -$4.46M |
|
970
Applied Digital
APLD
$4.78B
| $8M | 0.01% |
+1,046,595
| New | +$8M |
|
971
Global E Online
GLBE
$6.15B
| $7.99M | 0.01% |
+146,468
| New | +$7.99M |
|
972
Aptiv
APTV
$18.2B
| $7.93M | 0.01% |
131,140
-180,922
| -58% | -$10.9M |
|
|
HPP
973
Hudson Pacific Properties
HPP
$1.14B
| $7.89M | 0.01% |
2,605,516
+1,275,236
| +96% | +$3.86M |
|
974
Gartner
IT
$18.6B
| $7.87M | 0.01% |
16,254
-43,584
| -73% | -$21.1M |
|
975
Avanos Medical
AVNS
$568M
| $7.87M | 0.01% |
494,627
+148,902
| +43% | +$2.37M |
|